The endopeptidase inhibitor, candoxatril, and its therapeutic potential in the treatment of chronic cardiac failure in man

Author： McDowell G. Nicholls D.P.

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.1, 1999-01, pp. : 79-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Potential of Ghrelin in the Treatment of Heart Failure

By Nagaya Noritoshi Kangawa Kenji

Drugs, Vol. 66, Iss. 4, 2006-01 ,pp. : 439-448

Adis International

Access to resources Recommend Favorite

Vasopressin Receptor Antagonists: Therapeutic Potential in the Management of Acute and Chronic Heart Failure

By Russell S.D. DeWald T.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 1, 2003-01 ,pp. : 13-20

Adis International

Access to resources Recommend Favorite

The therapeutic potential of angiotensin II receptor blockers in the treatment of heart failure

By McKelvie Robert S

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 3, 2004-03 ,pp. : 245-253

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of Na-H exchange inhibitors for the treatment of heart failure

By Karmazyn M.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 835-843

Informa Healthcare

Access to resources Recommend Favorite

Lamivudine: A Review of its Therapeutic Potential in Chronic Hepatitis B

By Jarvis B. Faulds D.

Drugs, Vol. 58, Iss. 1, 1999-07 ,pp. : 101-141

Adis International

Access to resources Recommend Favorite